Biostatistics & Bioinformatics Seminar:

Efficacy of Wolbachia-Infected MosqAwarduito Deployments for the Control of Dengue

May 25, 2022 | 3 PM | Zoom

Abstract: We conducted a cluster-randomized trial involving releases of wMel-infected A. aegypti mosquitoes for the control of dengue, a mosquito-borne viral disease, in Yogyakarta, Indonesia. While our intention-to-treat (ITT) analysis of the trial data found the protective efficacy of the intervention was 77.1%, applying a spatiotemporal framework to evaluate the distribution of cases by intervention arm returns compelling evidence that the full intervention effect may be even larger.

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Nevan Krogan, PhD, in his role as Quantitative Biosciences Institute Director, led UCSF's largest award to date from the National Institute of Allergy and Infectious Diseases to establish one of nine Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern. Congrats, Nevan!

As the Center builds out its resources for affiliated faculty and staff, we encourage you to make use of our zoom backgrounds, simple slide deck template, or our logo for your upcoming presentations. Our Center Resources Library is currently under construction but feel free to click around!

The link below is restricted to Center-affiliated faculty only.

Please contact Sarah or Barbara if you have access issues or recommendations for the Center Resource Library.

The Center for Tuberculosis at UCSF wants to capture every success, funded project, and publication by its faculty. If you have news to share, please fill out this survey to keep our website updated.

Please contact the Center's manager, Sarah K. Hutch, for any CTB-related needs or questions.